Protocol for a pharmacogenomic study on individualised antipsychotic drug treatment for patients with schizophrenia

Background Schizophrenia is a severe and complex psychiatric disorder that needs treatment based on extensive experience. Antipsychotic drugs have already become the cornerstone of the treatment for schizophrenia; however, the therapeutic effect is of significant variability among patients, and onl...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yi Su, Hao Yu, Zhiren Wang, Sha Liu, Liansheng Zhao, Yingmei Fu, Yongfeng Yang, Bo Du, Fuquan Zhang, Xiangrong Zhang, Manli Huang, Cailan Hou, Guoping Huang, Zhonghua Su, Mao Peng, Ran Yan, Yuyanan Zhang, Hao Yan, Lifang Wang, Tianlan Lu, Fujun Jia, Keqing Li, Luxian Lv, Hongxing Wang, Shunying Yu, Qiang Wang, Yunlong Tan, Yong Xu, Dai Zhang, Weihua Yue
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Cambridge University Press 2021-07-01
Serie:	BJPsych Open
Soggetti:	Antipsychotics clinical trial schizophrenia drug interactions and side-effects genetics
Accesso online:	https://www.cambridge.org/core/product/identifier/S2056472421009455/type/journal_article
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!